Delivery Order SPE2DR25D3504-SPE2DR26F7BK7
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 17, 2025, by the Defense Logistics Agency for the supply of Twinrix vaccine in syringe format. The contract represents a firm fixed-price delivery order with a ceiling value of $2,073.96 and an ultimate completion date of November 18, 2025. This award was competitively awarded with no set-aside designation and is a child order issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Twinrix vaccine in syringe format, with a ceiling value of $17,246.08 and a firm fixed price structure. This non-competitive delivery order is set to conclude on May 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,296.11 delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe format on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,822.80 for TWINRIX vaccine syringes (1mL, 10-count units) under a firm fixed-price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive, non-set-aside procurement. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $25,946.28 delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis without set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,278.50 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe form. This contract, designated as a firm fixed price delivery order with no set-aside, was awarded on September 19, 2025, with an ultimate completion date of September 22, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,111.33 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format, with completion targeted for November 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $5,707.70 to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order...
- The Defense Logistics Agency awarded a $7,734.62 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Twinrix vaccine syringes. This non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7BK7Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,044.58 by the Defense Logistics Agency (DLA) on December 4, 2025, for the supply of Twinrix vaccine in syringe format. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a broad range of medications, vaccines, and medical commodities to support military and veteran healthcare systems. The DLA Medical Supply Chain relies on AmerisourceBergen's extensive portfolio to deliver essential pharmaceutical products globally. This specific delivery order for Twinrix vaccine reflects the company's ongoing role in supporting Defense Health Agency and other government healthcare system immunization requirements through the broader pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/3/25 |